Raymond James reiterates Strong Buy on Mirum stock after trial data

🌐 Investing.com (Cyprus) —
Raymond James reiterates Strong Buy on Mirum stock after trial data

AI Summary

Raymond James reiterated its Strong Buy rating on Mirum stock following the release of trial data. The article provides no further details about the results or their implications for the company.

Markets Health Raymond James Mirum stock rating Strong Buy clinical trial trial data

Read original source →